Tag: Ibutamoren

The Safety and Efficacy of Growth Hormone Secretagogues

This review assesses the safety and efficacy of growth hormone secretagogues (GHSs), including ghrelin mimetics and GHRH analogs, as alternatives to recombinant GH therapy. GHSs like ibutamoren, anamorelin, and macimorelin stimulate endogenous GH release, offering potential benefits in conditions such as GH deficiency, sarcopenia, and cachexia. Clinical studies indicate improvements

Read More »

Stimulation of the Growth Hormone (GH)-Insulin-Like Growth Factor I Axis by Daily Oral Administration of a GH Secretagogue (MK-677) in Healthy Elderly Subjects

This 1996 randomized, double-blind, placebo-controlled study by Chapman et al. investigated the effects of MK-677, an orally active growth hormone secretagogue, on the GH/IGF-I axis in healthy elderly individuals aged 64–81. Participants received daily doses of 2, 10, or 25 mg of MK-677 or placebo over two treatment periods (14

Read More »